(Total Views: 270)
Posted On: 06/21/2022 1:35:59 PM
Post# of 116

$IONS News Article - Ionis announces eplontersen met co-primary and secondary endpoints in interim analysis of the Phase 3 NEURO-TTRansform study for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) https://marketwirenews.com/news-releases/ioni...63848.html


My Twitter: WhyteStocks